Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Akay Natural Ingredients Private Limited operates in the Biotechnology & Pharmaceuticals technology area. The portfolio currently contains 1 pending office action. This action is handled by 1 distinct examiner and is located within 1 distinct art unit. The focus on 1 distinct art unit suggests that the company's current Biotechnology & Pharmaceuticals activity is concentrated in 1 technical field.
TIEN, LUCY MINYU is the busiest examiner for the company, currently managing 1 pending office action. The data indicates a concentrated prosecution profile, with 1 examiner and 1 art unit involved in the company's current patent activity. This means that TIEN, LUCY MINYU is the sole examiner responsible for the company's active workload. With 1 pending office action and 1 distinct examiner, the prosecution process is concentrated. This profile allows for interaction with the patent office and affects the management of the company's pending intellectual property matters in the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TIEN, LUCY MINYU | 1 | 59.1% | +36.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18564462 | NUTRACEUTICAL COMPOSITION FOR DELIVERY OF HYDROPHILIC AND HYDROPHOBIC BIOACTIVE SUBSTANCES | TIEN, LUCY MINYU | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18564462 | NUTRACEUTICAL COMPOSITION FOR DELIVERY OF HYDROPHILIC AND HYDROPHOBIC BIOACTIVE SUBSTANCES | TIEN, LUCY MINYU | 1612 | §103DP | Final Rejection | — | Pending | Nov 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAkay Natural Ingredients Private Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Lucy Minyu Tien has the most, with 1 of Akay Natural Ingredients Private Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
